Following the news on 17th July that Roche has announced positive top-line results from its Phase III trial for influenza drug, Xofluza, Tom Moore, Senior Healthcare...
Net sales grew 5percent (cc, +7 percent USD) mainly driven by: Cosentyxgrew to USD 701 million, (+40 percent cc) with strong growth in all indications in...
Pfizer Inc. and Eli Lilly and Company announced that a 16-week Phase 3 study in patients with osteoarthritis (OA) pain evaluating subcutaneous administration of tanezumab, an...
Sanofi and Revolution Medicines, Inc. announced an exclusive worldwide partnership to develop and commercialize targeted therapies, based on the biology of the cellular enzyme SHP2, for...
PHC Corporation, a wholly-owned subsidiary of PHC Holdings Corporation has introduced a new -85°C ultra-low temperature freezer VIP ECO series using natural refrigerants and new inverter...
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the US Food and Drug Administration (FDA) has approved SYMTUZA, the first and only complete, darunavir-based...
Vizient, Inc., announced the product categories and supplier savings opportunities available as part of its Quarter 3 National Group Buys Program available July 1 through September...
Walmart and Microsoft on Tuesday signed a five-year engineering partnership to bring the fight against online giant Amazon to the artificial intelligence, cloud computing and retail...
Agilent Technologies Inc. announced that it has completed the acquisition of the business assets of ULTRA Scientific, Inc., a leading provider of chemical standards and certified...
Johnson & Johnson announced sales of USD 20.8 billion for the second quarter of 2018, an increase of 10.6 percent as compared to the second quarter of 2017....
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced that on Wednesday, August 1, 2018, after market close, the Company will release...
Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, will report financial results for the second quarter 2018 on Tuesday, August...
Pfizer Inc. and Spark Therapeutics announced that Pfizer initiated a Phase 3 open-label, multi-center, lead-in study (NCT03587116) to evaluate the efficacy and safety of current factor...
AbbVie announced patent license agreements with Mylan over its proposed biosimilar adalimumab product. Under the terms of the agreements, AbbVie will grant Mylan a non-exclusive license...
UnitedHealth Group reported second quarter results, with continued strong, well-diversified performance across the enterprise. “Today, UnitedHealth Group delivers increasing value to more people, driven by strong...
Copyright © 2024 Medical Buyer